Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$9.23−0.13 (-1.39%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Telix Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Telix Pharmaceuticals's cash was $251.91M at Jun 30, 2026. For fiscal 2025 it was $141.87M, down 67.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.87M | -67.8% |
| FY2024 | Dec 31, 2024 | $440.00M | +422.0% |
| FY2023 | Dec 31, 2023 | $84.30M | +7.0% |
| FY2022 | Dec 31, 2022 | $78.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $251.91M | +198.8% |
| Q4 FY2025 | Dec 31, 2025 | $141.87M | +80.1% |
| Q2 FY2025 | Jun 30, 2025 | $207.16M | – |
| Q4 FY2024 | Dec 31, 2024 | $440.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $84.30M | – |
| Q4 FY2022 | Dec 31, 2022 | $78.78M | – |
See a number that looks wrong?